United Therapeutics | UTHR - Ebit

Stock Price
478.27
Daily Change
3.27 0.69%
Monthly
-2.33%
Yearly
35.32%
Q1 Forecast
455.03

United Therapeutics reported $389.3M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Amarin USD -1.7M 8.47M Sep/2025
Ardelyx USD 7.12M 19.62M Sep/2025
Baxter International USD 201.2M 70.8M Sep/2025
Bayer EUR -399M 363M Sep/2025
Biogen USD 659.6M 157M Sep/2025
BioMarin Pharmaceutical USD -31.69M 308.58M Sep/2025
Gilead Sciences USD 3.51B 810M Sep/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
Halozyme Therapeutics USD 217.92M 15.48M Sep/2025
Insmed USD -261.35M 7.48M Sep/2025
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
J&J USD 5.11B 2.3B Dec/2025
Moderna USD -260M 557M Sep/2025
Pfizer USD 4.57B 1.97B Sep/2025
PTC Therapeutics USD 3.49M 38.35M Sep/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Sarepta Therapeutics USD -62.88M 178.46M Sep/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025
United Therapeutics USD 389.3M 112.4M Sep/2025
Vertex Pharmaceuticals USD 1.24B 84.6M Sep/2025